Information by Drug Class
FDA provides consumers and industry with safety, regulatory and availability information for various drugs by drug class. From A to…
FDA Drug Safety Communication: FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings
An FDA review found the side effects on mood, behavior, or thinking with the stop-smoking medicines Chantix (varenicline) and Zyban…
FDA Roundup: March 14, 2025
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan)
Stay informed on FDA updates and press announcements about recalls involving angiotensin II receptor blockers (ARBs) like valsartan and losartan.…
Novel Drug Approvals for 2022
Innovative drugs often mean new treatment options for patients and advances in health care for the American public.
NMFTA aims to simplify freight classification with new tool
The ClassIT+ platform, coming this summer, contains several upgrades intended to ease changes for shippers and carriers.
USPS will work with Elon Musk’s DOGE to cut costs
The agency plans to cut 10,000 employees via early retirement as it seeks further reform, Postmaster General Louis DeJoy said.
How Foot Locker’s supply chain is lacing up for the future
Better inventory management and stronger vendor collaboration is helping the sneaker retailer advance its companywide transformation plan.
Global top-3 memory maker status, 4Q24
The global top-3 memory makers are expected to see weakening operating performance in the first quarter of 2025, and will…
Foxconn forecasts over 100% AI server revenue surge in 1Q25
Foxconn, the world’s largest electronics contract manufacturer, announced record-breaking revenue for 2024, reaching NT$6.86 trillion (US$216 billion). The milestone, revealed…